Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2023 Update
Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2023 Update
Summary
GlobalData's Medical Devices sector report, “Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Reproductive Health Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Reproductive Health Devices includes Endometrial Ablation Devices, Female Sterilization Devices, Reversible Contraceptive Devices and Assisted Reproductive Technology Devices.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Reproductive Health Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Reproductive Health Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Reproductive Health Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Reproductive Health Devices Overview
Products under Development
Reproductive Health Devices - Pipeline Products by Stage of Development
Table Figure 1: Reproductive Health Devices - Pipeline Products by Stage of Development
Table Reproductive Health Devices - Pipeline Products by Stage of Development
Reproductive Health Devices - Pipeline Products by Segment
Table Figure 2: Reproductive Health Devices - Pipeline Products by Segment
Table Reproductive Health Devices - Pipeline Products by Segment
Reproductive Health Devices - Pipeline Products by Territory
Table Figure 3: Reproductive Health Devices - Pipeline Products by Territory
Table Reproductive Health Devices - Pipeline Products by Territory
Reproductive Health Devices - Pipeline Products by Regulatory Path
Table Figure 4: Reproductive Health Devices - Pipeline Products by Regulatory Path
Table Reproductive Health Devices - Pipeline Products by Regulatory Path
Reproductive Health Devices - Pipeline Products by Estimated Approval Date
Table Figure 5: Reproductive Health Devices - Pipeline Products by Estimated Approval Date
Table Reproductive Health Devices - Pipeline Products by Estimated Approval Date
Reproductive Health Devices - Ongoing Clinical Trials
Table Figure 6: Reproductive Health Devices - Ongoing Clinical Trials
Table Reproductive Health Devices - Ongoing Clinical Trials
Reproductive Health Devices - Pipeline Products under Development by Companies
Reproductive Health Devices Companies - Pipeline Products by Stage of Development
Table Reproductive Health Devices Companies - Pipeline Products by Stage of Development
Reproductive Health Devices - Companies Pipeline Products by Stage of Development
Table Reproductive Health Devices - Companies Pipeline Products by Stage of Development
Reproductive Health Devices Companies and Product Overview
Table FemBloc - BLOC: Prospective, Multi-center, Study of Subjects Undergoing FemBloc Permanent Contraception with Two Confirmation Procedures (FemBloc with FemChec and Fluoro HSG)
Table FemBloc - FINALE: Prospective Multi-Center Trial for FemBloc Intratubal Occlusion for Transcervical Permanent Birth Control
Table FemBloc - Prospective Multi-center Office Based Bi-lateral Tubal Occlusion Trial for Female Permanent Contraception: BLOC
Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview
Table Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview
Table UPA - CVR - Product Status
Table UPA - CVR - Product Description
Table UPA - IUS - Product Status
Table UPA - IUS - Product Description
Lubrizol Life Science Health Company Overview
Lubrizol Life Science Health Pipeline Products & Ongoing Clinical Trials Overview
Table Lubrizol Life Science Health Pipeline Products & Ongoing Clinical Trials Overview
Table Contraceptive Vaginal System - Product Status
Table Contraceptive Vaginal System - Product Description
May Health Company Overview
May Health Pipeline Products & Ongoing Clinical Trials Overview
Table May Health Pipeline Products & Ongoing Clinical Trials Overview
Table Ovarian Rebalancing - Product Status
Table Ovarian Rebalancing - Product Description
Table May Health - Ongoing Clinical Trials Overview
Table Ovarian Rebalancing - ULTRA Study: a Feasibility, Prospective, Multicenter, Single-arm Trial of the May Health Device in Transvaginal Ablation of Ovarian Tissue Under ULTRAsound Visualisation in Women With Polycystic Ovary Syndrome (PCOS)
Memorial Sloan Kettering Cancer Center Company Overview
Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
Table Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
Table Barakat Automated Uterine Manipulator Device - Product Status
Table Felix - Clinical Assessment Study of Felix Device
Table Felix - Comparison of Clinical Outcomes of Infertile Men Candidate for ICSI Between Two Methods of Sperm Separation: Felix Device Based on Surface Electric Charge and Density Gradient Centrifugation (DGC)
Table Felix - The Felix Study: Assessing the Felix System Vs Swim-up and Discontinuous Gradient Centrifugation to Isolate Spermatozoa for Use in Assisted Reproductive Technology
Table OCON Medical Ltd - Ongoing Clinical Trials Overview
Table IUB SEAD - Phase IIa Clinical Study to Evaluate Intrauterine Drug Delivery Platform IUB SEAD
Table IUB SEAD - PHASE IIB PRE-PIVOTAL STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE IUB SEAD DEVICE IN WOMEN SUFFERING FROM HEAVY MENSTRUAL BLEEDING (HMB)
Table IUB SEAD - Phase IIc (Protocol 55P127): Addition of up to 10 Women to Explore Silver Systemic Absorption as a Continuation Study to: Phase IIb (Protocol 55P140)
Table VeraCept - A Phase III, Prospective, Multi-center, Single-arm, Open-label Study to Evaluate VeraCept, a Longacting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability
Table VeraCept - A Randomized, Single-blind, Comparative Bioavailability Study to Assess the Pharmacokinetic Properties of VeraCept Intrauterine Contraceptive Versus ParaGard in Healthy, Post-menarcheal Women
Shandong Junxiu Biotechnology Co Ltd Company Overview
ZR-Operculum, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table ZR-Operculum, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table ZRO Device - Product Status
Table ZRO Device - Product Description
Reproductive Health Devices- Recent Developments
Dec 06, 2023: Mosie Baby Becomes the First Company to Receive FDA Clearance for At-Home Intravaginal Insemination
Dec 06, 2023: Artificial Insemination Kit Granted FDA Clearance
Dec 04, 2023: Dare Bioscience Announces Commencement of Phase 3 Study of Ovaprene, an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Nov 06, 2023: Celanese Announces New Leadership Appointments to Enhance Value Creation
Nov 06, 2023: NN Reports Financial Results for Third Quarter 2023
Nov 06, 2023: Celanese Corporations Q3 2023 Earnings Report Strong Profitability and Revenue Growth with Room for Improvement
Oct 30, 2023: Sebela Women's Health Announces Further Positive Data From the Pivotal Phase 3 Study of the Investigational Copper 175 mm Intra-Uterine Device (IUD)
Oct 25, 2023: Femasys to Showcase FemBloc and its other Novel Products Advancing Women's Health at the American Association of Gynecologic Laparoscopic Surgeons
Sep 27, 2023: Femasys Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate
Sep 21, 2023: Dare Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology Dare-LARC1
Sep 20, 2023: Femasys Announces First-Patient-In for Pivotal Clinical Trial Evaluating its FemBloc Permanent Birth Control
Sep 14, 2023: First Real-World Observational Study of the JADA System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG's Obstetrics & Gynecology
Aug 22, 2023: NN Announces David Harrison as Chief Procurement Officer
Aug 18, 2023: DonneVie Medical Technology Receives 510(k) Clearance for Dewin Blastocyst Medium
Aug 03, 2023: Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc
Jul 27, 2023: Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
Jul 26, 2023: A Study Postulates Vaginal Self-Sample and Urine as Applicable Tools for Endometrial Cancer Diagnosis and Prognosis
Jul 13, 2023: Memphasys Granted Two New Australian Patents for the Felix System
Jun 27, 2023: NN Promotes Verlin Bush to Chief Commercial Officer
Jun 26, 2023: Femasys Announces FDA Approval of Its IDE for the Pivotal Clinical Trial of Fembloc Permanent Birth Control, a Non-surgical Alternative for Women
Jun 26, 2023: May Health Announces Data From Feasibility Studies of its Novel Ovarian Rebalancing Treatment and Receives Approval From FDA for Pivotal Trial
Jun 21, 2023: Revolutionising Reproductive And Sexual Health: LifeCell Launches Advanced Self- Collection Healthcare Services
Jun 06, 2023: Study Shows Felix System Offers Significant Advantages Over Alternative Sperm Separation Techniques on Cryopreserved Semen
May 25, 2023: Zhejiang Horizon Medical Technology receives 510(k) clearance for CryoX Vitrification Freeze Kit / Thaw Kit
May 18, 2023: Sebela Women's Health announces positive phase 3 data for its investigational, nextgeneration, hormone-free, low-dose copper intrauterine device (IUD)
May 11, 2023: Femasys to showcase four products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting
Mar 16, 2023: Aspivix announces the publication, in contraception, an international reproductive health journal, of the first-in-women study results using its novel cervical stabilizer in IUD procedures
Mar 09, 2023: NN Reports Financial Results For Fourth Quarter and Full Year 2022
Feb 20, 2023: ARTSMedia receives 510(k) clearance for ARTSMedia In Vitro Culture Medium (AM-IVC Medium)
Feb 16, 2023: Hologic secures approval for NovaSure V5 GEA device in Canada and Europe
Feb 13, 2023: Vitromed receives 510(k) clearance for V-SPERM WASH
Feb 07, 2023: KOL testings demonstrate Felix System outperforms DGC
Jan 10, 2023: HorizonMedical's Daylily Embryo Transfer Catheter obtains FDA 510(k) Approval
Dec 26, 2022: Shanghai Horizon Medical Technology receives 510(k) clearance for Daylily Embryo Transfer Catheter